货号:GS40602
Retifanlimab is a humanized monoclonal antibody targeting programmed death protein 1 (PD-1). It blocks the PD-1/PD-L1 interaction, restoring T cell function and enhancing anti-tumor immunity. It is being investigated for advanced solid tumors, including anal carcinoma and non-small cell lung cancer.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯